Siegel, Steven J.

Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier

Makadia, H. K., & Siegel, S. J. (2011) · Polymers

Advanced Drug Delivery Systemsbiodegradable polymer synthesis and properties

Cited by 4,816

Validating γ oscillations and delayed auditory responses as translational biomarkers of autism

Gandal, M. J., Edgar, J. C., Ehrlichman, R. S., Mehta, M., Roberts, T. P. L., & Siegel, S. J. (2010) · Biological Psychiatry

Autism Spectrum Disorder ResearchGenetics and Neurodevelopmental Disorders

Cited by 314

Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia.

Gandal, M. J., Edgar, J. C., Klook, K., & Siegel, S. J. (2012) · Neuropharmacology

Schizophrenia research and treatmentNeural dynamics and brain function

Cited by 269

Varenicline improves mood and cognition during smoking abstinence

Patterson, F., Jepson, C., Strasser, A. A., Loughead, J., Perkins, K. A., Gur, R. C., Frey, J. M., Siegel, S., & Lerman, C. (2009) · Biological Psychiatry

Smoking Behavior and CessationNicotinic Acetylcholine Receptors Study

Cited by 222

Effect of drug type on the degradation rate of PLGA matrices

SIEGEL, S., KAHN, J., METZGER, K., WINEY, K., WERNER, K., & DAN, N. (2006) · European Journal of Pharmaceutics and Biopharmaceutics

Advanced Drug Delivery Systemsbiodegradable polymer synthesis and properties

Cited by 208

GABAB-mediated rescue of altered excitatory–inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction

Gandal, M. J., Sisti, J., Klook, K., Ortinski, P. I., Leitman, V, Liang, Y., Thieu, T., Anderson, R., Pierce, R. C., Jonak, G., et al. (2012) · Translational Psychiatry

Neuroscience and Neuropharmacology ResearchSchizophrenia research and treatment

Cited by 204

Sensory processing in autism spectrum disorders and Fragile X syndrome—From the clinic to animal models

Sinclair, D., Oranje, B., Razak, K. A., Siegel, S. J., & Schmid, S. (2017) · Neuroscience & Biobehavioral Reviews

Autism Spectrum Disorder ResearchGenetics and Neurodevelopmental Disorders

Cited by 198

Withdrawal from Chronic Nicotine Administration Impairs Contextual Fear Conditioning in C57BL/6 Mice

Davis, J. A., James, J. R., Siegel, S. J., & Gould, T. J. (2005) · The Journal of Neuroscience

Memory and Neural MechanismsNicotinic Acetylcholine Receptors Study

Cited by 146

Dysbindin-1 mutant mice implicate reduced fast-phasic inhibition as a final common disease mechanism in schizophrenia

Carlson, G. C., Talbot, K., Halene, T. B., Gandal, M. J., Kazi, H. A., Schlosser, L., Phung, Q. H., Gur, R. E., Arnold, S. E., & Siegel, S. J. (2011) · Proceedings of the National Academy of Sciences

Schizophrenia research and treatmentNeuroscience and Neuropharmacology Research

Cited by 103

In vitro-in vivo correlations of scalable PLGA-risperidone implants for the treatment of schizophrenia

Amann, L. C., Gandal, M. J., Lin, R., Liang, Y., & Siegel, S. J. (2010) · Pharmaceutical Research

Advanced Drug Delivery SystemsSchizophrenia research and treatment

Cited by 99

Male-specific deficits in natural reward learning in a mouse model of neurodevelopmental disorders

Grissom, N. M., McKee, S. E., Schoch, H., Bowman, N., Havekes, R., O'Brien, W. T., Mahrt, E., Siegel, S., Commons, K., Portfors, C., et al. (2018) · Molecular Psychiatry

Neurotransmitter Receptor Influence on BehaviorGenetics and Neurodevelopmental Disorders

Cited by 92

Oxytocin reduces amygdala activity, increases social interactions, and reduces anxiety-like behavior irrespective of NMDAR antagonism

Sobota, R., Mihara, T., Forrest, A., Featherstone, R. E., & Siegel, S. J. (2015) · Behavioral Neuroscience

Neuroendocrine regulation and behaviorNeurotransmitter Receptor Influence on Behavior

Cited by 80

In vitro and in vivo demonstration of risperidone implants in mice

Rabin, C., Liang, Y., Ehrlichman, R. S., Budhian, A., Metzger, K. L., Majewski-Tiedeken, C., Winey, K. I., & Siegel, S. J. (2008) · Schizophrenia Research

Advanced Drug Delivery SystemsSchizophrenia research and treatment

Cited by 64

Mouse Model of Chromosome 15q13.3 Microdeletion Syndrome Demonstrates Features Related to Autism Spectrum Disorder

Kogan, J. H., Gross, A. K., Featherstone, R. E., Shin, R., Chen, Q., Heusner, C. L., Adachi, M., Lin, A., Walton, N. M., Miyoshi, S., et al. (2015) · The Journal of Neuroscience

Genomic variations and chromosomal abnormalitiesGenetics and Neurodevelopmental Disorders

Cited by 59

Multiple drug treatments that increase cAMP signaling restore long-term memory and aberrant signaling in fragile X syndrome models

Choi, C. H., Schoenfeld, B. P., Bell, A. J., Hinchey, J., Rosenfelt, C., Gertner, M. J., Campbell, S. R., Emerson, D., Hinchey, P., Kollaros, M., et al. (2016) · Frontiers in Behavioral Neuroscience

Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research

Cited by 46

A rapid method for creating drug implants: Translating laboratory-based methods into a scalable manufacturing process

Wang, C., Wang, W., Meyer, R. F., Liang, Y., Winey, K. I., & Siegel, S. J. (2010) · Journal of Biomedical Materials Research Part B: Applied Biomaterials

Advanced Drug Delivery SystemsNanoparticle-Based Drug Delivery

Cited by 33

Sociability development in mice with cell-specific deletion of the NMDA receptor NR1 subunit gene

Ferri, S. L., Pallathra, A. A., Kim, H., Dow, H. C., Raje, P., McMullen, M., Bilker, W. B., Siegel, S. J., Abel, T., & Brodkin, E. S. (2020) · Genes, Brain and Behavior

Neuroscience and Neuropharmacology ResearchGenetics and Neurodevelopmental Disorders

Cited by 15